VEGFA and non-small cell lung carcinoma: Meanwhile, Lijun L et al. have elaborated that in the treatment of non-small cell lung cancer with anlotinib, suppressed VEGFA signal facilitates to restrain the activities of HUVECs (Liang et al., 2019).